Skip to main content
  • U.S. Department of Health & Human Services
National Institutes of Health (NIH) - Turning Discovery into Health
  • Virtual Tour
  • En Español

Site Menu

  • Home
  • Health Information
    • Health Care Providers & Facilities
    • Health Info Lines
    • HealthCare.gov
    • Science Education Resources
    • NIH Clinical Research Trials and You
    • Talking to Your Doctor

    More »

    Quick Links

    • MedlinePlus Health Info
    • NIH News in Health
    • Wellness Toolkits
  • Grants & Funding
    • Grants Home Page
    • Find Funding
    • Due Dates
    • How to Apply
    • About Grants
    • Policy & Compliance
    • Grants News/Blog
    • Contracts
    • Loan Repayment

    More »

    Quick Links

    • RePORT
    • eRA Commons
    • NIH Common Fund
  • News & Events
    • News Releases
    • Digital Media Kits
    • Media Resources
    • Media Contacts
    • Images and B-roll
    • Events
    • Social Media

    More »

    Quick Links

    • NIH News in Health
    • NIH Research Matters
    • NIH Record
  • Research & Training
    • Medical Research Initiatives
    • Science Highlights
    • Science Education
    • Research in NIH Labs & Clinics
    • Training Opportunities
    • Library Resources
    • Research Resources
    • Clinical Research Resources
    • Safety, Regulation and Guidance

    More »

    Quick Links

    • PubMed
    • Stem Cell Information
    • OppNet
    • NIDB
    • NIH Blueprint for Neuroscience Research
  • Institutes at NIH
    • List of Institutes and Centers
    • NIH Office of the Director
    • Directors of NIH Institutes and Centers
    • NIH Institute and Center Contact Information

    More »

    Quick Links

    • NCI
    • NEI
    • NHLBI
    • NHGRI
    • NIA
    • NIAAA
    • NIAID
    • NIAMS
    • NIBIB
    • NICHD
    • NIDCD
    • NIDCR
    • NIDDK
    • NIDA
    • NIEHS
    • NIGMS
    • NIMH
    • NIMHD
    • NINDS
    • NINR
    • NLM
    • CC
    • CIT
    • CSR
    • FIC
    • NCATS
    • NCCIH
  • About NIH
    • Who We Are
    • What We Do
    • Jobs at NIH
    • Visitor Information
    • Frequently Asked Questions
    • Contact Us

    More »

    Quick Links

    • The NIH Director
    • Take the Virtual Tour
    • NIH…Turning Discovery Into Health®
    • Impact of NIH Research
    • Science, Health, and Public Trust

You are here

Home » News & Events » News Releases

News Releases

News Release

Thursday, April 17, 2014

Jump-starting natural resilience reverses stress susceptibility

Compensatory response shields mice from depression-like behaviors – NIH-funded study.

Chart describing antidepressant effects. Researchers produced antidepressant-like behavioral effects by reversing out-of-balance electrical activity in reward circuit neurons of susceptible mice exposed to social stress. Increasing an excitatory current triggered a compensatory increase in a potassium channel current – as did activating the potassium channel using pulses of light in mice with brain circuitry engineered to respond to it.Ming-Hu Han, Ph.D., Icahn School of Medicine at Mount Sinai

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain’s reward circuit and experimentally reversed it – but there’s a twist.

Instead of suppressing it, researchers funded by the National Institutes of Health boosted runaway neuronal activity even further, eventually triggering a compensatory self-stabilizing response. Once electrical balance was restored, previously susceptible animals were no longer prone to becoming withdrawn, anxious, and listless following socially stressful experiences.

“To our surprise, neurons in this circuit harbor their own self-tuning, homeostatic mechanism of natural resilience,” explained Ming-Hu Han, Ph.D ., of the Icahn School of Medicine at Mount Sinai, New York City, a grantee of the NIH’s National Institute of Mental Health (NIMH) and leader of the research team.

Han and colleagues report on their discovery April 18, 2014 in the journal Science.

“As we get to the bottom of a mystery that has perplexed the field for more than a decade, the story takes an unexpected twist that may hold clues to future antidepressants that would act through this counterintuitive resilience mechanism.” said NIMH Director Thomas R. Insel, M.D.

Prior to the new study, the researchers had turned resilience to social stress on and off by using pulses of light to manipulate reward circuit neuronal firing rates in genetically engineered mice – optogenetics. But they didn’t know how resilience worked at the cellular level.

To find out, they focused on electrical events in reward circuit neurons of mice exposed to a social stressor. Some mice that experience repeated encounters with a dominant animal emerge behaviorally unscathed, while others develop depression-like behaviors.

Neurons that secrete the chemical messenger dopamine from a reward circuit hub called the ventral tegmental area (VTA) become abnormally hyperactive in the susceptible mice. This excess activation is known to be triggered by an excitatory electrical current that drives cell firing. Han and colleagues were surprised to discover that this excitatory current was even higher in the stress-resilient mice even though they were spared the runaway dopamine activity and depression-related behaviors. Yet neurons of these resilient mice also showed a simultaneous increase in inhibitory potassium channel currents.

This prompted the researchers to hypothesize that in resilient animals the runaway excitatory current triggers the boost in the inhibitory current in a self-balancing mechanism, resulting in normal mood-related behaviors. By this logic, perhaps the susceptible mice just needed a boost in excitatory currents to activate their compensatory currents.

To test this, Han’s team repeatedly infused the VTA of susceptible mice, over five days, with a drug known to increase the excitatory current. As hypothesized, the animals showed a profound reversal in behaviors and antidepressant-like effects – they socialized more and their characteristic rodent sweet tooth came back.

At the cellular level, this was accompanied by a marked increase in both the excitatory and inhibitory currents, resulting in normalized neuronal activity. The drug the mice received, lamotrigine, is clinically used as a mood stabilizer to treat the depressed phase of bipolar disorder – and the researchers may have discovered its mechanism of action.

Han and colleagues also achieved similar results using chronic optogenetic stimulation to drive up the neuronal activity. However, they discovered that the homeostatic mechanism seems to work specifically in the reward circuit – projections of the VTA to the nucleus accumbens – and not in VTA projections to the prefrontal cortex.

The abnormally high excitatory current that develops in response to social stress –if driven high enough for a sustained period – triggers its own compensatory adaptation, the inhibitory currents that corrects out-of-balance electrical activity and produces resilience. So at least in the brain’s reward circuit, exaggerating an abnormality, for a time, proved to be the curative secret , say the researchers.

“Homeostatic mechanisms finely regulate other critical components of physiology required for survival – blood glucose and oxygen, body temperature, blood pressure,” explained Lois Winsky, Ph.D., chief of the NIMH Molecular, Cellular, and Genomic Neuroscience Research Branch, which funded the study. “Similar mechanisms appear to also maintain excitatory balance in brain cells. This study shows how they may regulate circuits underlying behavior. ”

Grants: MH092306, MH095425, MH087004, MH096464

About the National Institute of Mental Health (NIMH): The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery and care. For more information, visit http://www.nimh.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health®

Reference

Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience. Friedman AK, Walsh JJ, Juarez B, Ku SM, Chaudury D, Wan J, Li X, Dietz DM, Vialou VF, Neve RL, Yue A, Han M-H. Science, April 18, 2014.

###

Institute/Center

National Institute of Mental Health (NIMH)

Contact

Jules Asher
301-443-4536

Multimedia

Dr. Han describes his 'Rising Star' research proposal to develop potential preliminary forms of a new class of 'active' antidepressant medications.

Dr. Han describes his 'Rising Star' research proposal to develop potential preliminary forms of a new class of 'active' antidepressant medications.

Connect with Us

  • Subscribe to news releases
  • RSS Feed

Connect with Us

  • Contact Us
  • X
  • Facebook
  • Instagram
  • YouTube
  • Flickr
  • More Social Media from NIH

Footer

  • NIH Home
  • Virtual Tour
  • En Español
  • Visitor Information
  • Frequently Asked Questions
  • Privacy Policy
  • Disclaimers
  • Accessibility
  • NIH Website Archives
  • Nondiscrimination Notice
  • Freedom of Information Act
  • No Fear Act
  • HHS Vulnerability Disclosure
  • Office of Inspector General
  • USA.gov

NIH…Turning Discovery Into Health®

National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

U.S. Department of Health and Human Services

Back to Top